HighLife develops catheter-based mitral valve replacement technology, enabling non-surgical cardiac valve procedures.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€80,000,000
Total raised
-
Valuation
-
Employees
2010
Founded
Latest round
Growth - September 22, 2026
Growth - €80,000,000
September 22, 2026
European Investment Bank (EIB, public body, held as text), BNP Paribas Développement (corporate, held as text), Capricorn Partners, Critical Path Ventures, Pro Benefis Familiae, SPRIM Global Investments, USVP, Sectoral, VI Partners
✓ verified by our desk
Open roles
HighLife is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile